Author

Okoyenta Celestina Onyinye

Institution: Nigerian Institute of Medical Research

Observed institution: Nigerian Institute of Medical Research

OpenAlex ID: A5121860424

Establishing FDA-approved oncology drugs as GPR176 inhibitor through homology modelling, molecular docking, MMGBSA, DFT, and molecular dynamics simulation

2026 · Felix Oluwasegun Ishabiyi, Haruna Isiyaku Umar, et al. · Scientific Reports · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: